| Literature DB >> 6420563 |
A J Crisp, R J Coughlan, D Mackintosh, B Clark, G S Panayi.
Abstract
Elevated plasma levels of beta 2 microglobulin have been described in rheumatoid arthritis (RA) but their relationship to disease activity is unclear. In patients treated for 6 months with auranofin (AF) there was a significant fall (p less than 0.05) in beta 2M levels pari passu with improvement in disease activity as measured by a fall in C-reactive protein. In addition, 26 patients with mild RA had beta 2M levels within the normal range. It is concluded that beta 2M plasma levels reflect disease activity in RA.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6420563
Source DB: PubMed Journal: J Rheumatol ISSN： 0315-162X Impact factor: 4.666